Programme17 – Inhibitors 2018

09:00

Lecture: Evolving inhibitor incidence over time
Frits R. Rosendaal (The Netherlands)

09:30	SESSION 3: Treatment of inhibitors in hemophilia Chairs: Sébastien Lacroix-Desmazes (France) and Michael Makris (UK)
	Development of SerpinPC as a pan-haemophilia agent Jim Huntington (UK)
	Standard and novel approaches for treatment and prevention of bleeding episodes in patients with inhibitors Roseline D’OIRON (France)
	CAR/BAR mediated treatment of haemophilia A Christoph Konigs (Germany)

11:30	SESSION 3 (continued) Chairs: Sébastien Lacroix-Desmazes (France) and Michael Makris (UK)
	How to measure the efficacy of treatment in patients with inhibitors (Laboratory assays) Steven Kitchen (UK)
	How to manage surgery in inhibitors patients with standard and novel therapies Maria Elisa Mancuso (Italy)
	Conclusive remarks Flora Peyvandi (Italy)